Health Alert: Skin cancer vaccine shows promise of preventing melanoma from recurring
An experimental drug that uses messenger RNA to deliver a vaccine customized to a patient’s tumors effectively prevented skin cancer recurrence in a large-scale clinical trial, according to new results announced by drugmakers Moderna and Merck.
An experimental drug that uses messenger RNA to deliver a vaccine customized to a patient’s tumors effectively prevented skin cancer recurrence in a large-scale clinical trial, according to new results announced by drugmakers Moderna and Merck.
No comments:
Post a Comment